Cancer staging (TNM) — what the numbers mean

A plain-language explanation of the TNM staging system — what T, N, and M stand for and how they combine into Stages I, II, III, and IV.

“What stage is it?” is usually the first question after “Is it cancer?” Stage is the most important single determinant of prognosis and treatment plan. Most cancers are staged using the TNM system, developed by the American Joint Committee on Cancer (AJCC).

TNM: what each letter means

T — Tumor

How large the primary tumor is, and how deeply it has grown into nearby tissue. T is usually written as T0, Tis, T1, T2, T3, or T4:

T0 — no evidence of a primary tumor
Tis — “in situ.” Cancer cells present but confined to where they started, not yet invasive
T1 through T4 — increasing size or depth of invasion. T1 is smallest/least invasive; T4 is largest or most invasive

The exact size cutoffs depend on cancer type. A T1 breast cancer is ≤2 cm; a T1 colon cancer has invaded only into the submucosa.

N — Nodes

Whether cancer has spread to nearby (regional) lymph nodes:

N0 — no regional lymph node involvement
N1, N2, N3 — increasing numbers or extent of affected nodes

Lymph node involvement typically indicates the cancer has the capacity to spread further and often drives whether systemic (whole-body) treatment is recommended.

M — Metastasis

Whether cancer has spread to distant sites (other organs, bones, brain, distant lymph nodes):

M0 — no distant spread
M1 — distant metastasis present

M1 disease is Stage IV by definition for most cancers.

How T, N, M combine into overall stage

The three letters combine into a single overall stage — I, II, III, or IV — with Roman numerals. The combinations are cancer-specific, but the general pattern:

Stage I — small, localized, no node involvement, no metastasis (T1 N0 M0)
Stage II — larger tumor or limited node involvement, no metastasis
Stage III — significant local spread and/or more extensive node involvement, no distant metastasis
Stage IV — distant metastasis present (any T, any N, M1)

Some cancers add sub-stages (IA, IB, IIA, IIB, etc.) for finer prognostic resolution.

Clinical stage vs pathologic stage

Clinical stage (cTNM) is assigned before treatment, based on exam and imaging
Pathologic stage (pTNM) is assigned after surgery, based on what the pathologist found in the removed tissue

Pathologic stage is more accurate because it’s based on direct tissue examination. It can differ from clinical stage in either direction.

What stage is not

Stage is not grade. Grade (1–3) describes how abnormal the cells look. A grade 3 Stage I cancer is small but aggressive-looking. Both stage and grade matter.
Stage is not a prognosis. Average outcomes by stage exist, but your specific prognosis depends on cancer subtype, biomarkers, age, overall health, and treatment response.
Stage doesn’t change after initial diagnosis. If cancer progresses or recurs, oncologists describe it as “metastatic” or “recurrent” but don’t “restage” — the original stage is fixed in the record.

Cancer-specific staging systems

Some cancers use their own systems in addition to (or instead of) TNM:

Prostate cancer — TNM + Gleason score (tumor grade) + PSA level
Blood cancers (leukemia, lymphoma, myeloma) — often use Ann Arbor (lymphoma), Rai or Binet (CLL), R-ISS (myeloma), or other disease-specific systems — not TNM
Gynecologic cancers — FIGO staging (International Federation of Gynecology and Obstetrics), which maps roughly onto TNM
Melanoma — TNM + Breslow depth + ulceration status

If your cancer doesn’t use TNM, your oncologist will explain the system that applies.

What to ask your oncologist

“What stage and grade is my cancer?”
“Is this clinical stage or pathologic stage?”
“What staging system are we using — TNM, or something else?”
“What does this stage mean for treatment options?”
“Are there newer staging subclassifications I should know about?” (AJCC updates are periodic.)
“What was the staging workup — what imaging did we do?”